Logo image of EDAP

EDAP TMS SA -ADR (EDAP) Stock Fundamental Analysis

NASDAQ:EDAP - Nasdaq - US2683111072 - ADR - Currency: USD

2.54  +0.07 (+2.83%)

Fundamental Rating

3

EDAP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. EDAP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EDAP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EDAP had negative earnings in the past year.
In the past year EDAP has reported a negative cash flow from operations.
In multiple years EDAP reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: EDAP reported negative operating cash flow in multiple years.
EDAP Yearly Net Income VS EBIT VS OCF VS FCFEDAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -23.13%, EDAP is in line with its industry, outperforming 50.00% of the companies in the same industry.
With a Return On Equity value of -37.20%, EDAP perfoms like the industry average, outperforming 56.84% of the companies in the same industry.
Industry RankSector Rank
ROA -23.13%
ROE -37.2%
ROIC N/A
ROA(3y)-8.37%
ROA(5y)-5.07%
ROE(3y)-13.3%
ROE(5y)-8.18%
ROIC(3y)N/A
ROIC(5y)N/A
EDAP Yearly ROA, ROE, ROICEDAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 40.40%, EDAP is doing worse than 69.47% of the companies in the same industry.
EDAP's Gross Margin has been stable in the last couple of years.
EDAP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.89%
GM growth 5Y-1.32%
EDAP Yearly Profit, Operating, Gross MarginsEDAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

EDAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
EDAP has about the same amout of shares outstanding than it did 1 year ago.
EDAP has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EDAP has been reduced compared to a year ago.
EDAP Yearly Shares OutstandingEDAP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
EDAP Yearly Total Debt VS Total AssetsEDAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

A Debt/Equity ratio of 0.08 indicates that EDAP is not too dependend on debt financing.
EDAP has a better Debt to Equity ratio (0.08) than 63.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.67%
EDAP Yearly LT Debt VS Equity VS FCFEDAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

EDAP has a Current Ratio of 2.84. This indicates that EDAP is financially healthy and has no problem in meeting its short term obligations.
EDAP has a Current ratio (2.84) which is comparable to the rest of the industry.
EDAP has a Quick Ratio of 2.30. This indicates that EDAP is financially healthy and has no problem in meeting its short term obligations.
EDAP has a Quick ratio of 2.30. This is comparable to the rest of the industry: EDAP outperforms 54.74% of its industry peers.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio 2.3
EDAP Yearly Current Assets VS Current LiabilitesEDAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for EDAP have decreased by -1.72% in the last year.
Looking at the last year, EDAP shows a quite strong growth in Revenue. The Revenue has grown by 9.64% in the last year.
EDAP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.05% yearly.
EPS 1Y (TTM)-1.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
Revenue 1Y (TTM)9.64%
Revenue growth 3Y13.2%
Revenue growth 5Y9.05%
Sales Q2Q%11.6%

3.2 Future

Based on estimates for the next years, EDAP will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.96% on average per year.
The Revenue is expected to grow by 22.12% on average over the next years. This is a very strong growth
EPS Next Y1.46%
EPS Next 2Y10.61%
EPS Next 3Y12.45%
EPS Next 5Y18.96%
Revenue Next Year7.1%
Revenue Next 2Y11.23%
Revenue Next 3Y12.25%
Revenue Next 5Y22.12%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EDAP Yearly Revenue VS EstimatesEDAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
EDAP Yearly EPS VS EstimatesEDAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

EDAP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EDAP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EDAP Price Earnings VS Forward Price EarningsEDAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EDAP Per share dataEDAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as EDAP's earnings are expected to grow with 12.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.61%
EPS Next 3Y12.45%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EDAP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EDAP TMS SA -ADR

NASDAQ:EDAP (3/7/2025, 8:21:03 PM)

2.54

+0.07 (+2.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners41.81%
Inst Owner Change-1.59%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap94.24M
Analysts84.44
Price Target10.88 (328.35%)
Short Float %0.11%
Short Ratio0.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-111.18%
Min EPS beat(2)-221.82%
Max EPS beat(2)-0.54%
EPS beat(4)0
Avg EPS beat(4)-243.06%
Min EPS beat(4)-577.07%
Max EPS beat(4)-0.54%
EPS beat(8)3
Avg EPS beat(8)-394.22%
EPS beat(12)5
Avg EPS beat(12)-241.05%
EPS beat(16)6
Avg EPS beat(16)-187.03%
Revenue beat(2)1
Avg Revenue beat(2)-8.95%
Min Revenue beat(2)-23.46%
Max Revenue beat(2)5.57%
Revenue beat(4)2
Avg Revenue beat(4)-5.67%
Min Revenue beat(4)-23.46%
Max Revenue beat(4)5.57%
Revenue beat(8)4
Avg Revenue beat(8)-1.4%
Revenue beat(12)4
Avg Revenue beat(12)-3.09%
Revenue beat(16)6
Avg Revenue beat(16)2.3%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.44
P/FCF N/A
P/OCF N/A
P/B 1.52
P/tB 1.59
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS1.77
BVpS1.67
TBVpS1.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.13%
ROE -37.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.4%
FCFM N/A
ROA(3y)-8.37%
ROA(5y)-5.07%
ROE(3y)-13.3%
ROE(5y)-8.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.89%
GM growth 5Y-1.32%
F-Score3
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 224.57%
Cap/Sales 7.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.84
Quick Ratio 2.3
Altman-Z N/A
F-Score3
WACC7.67%
ROIC/WACCN/A
Cap/Depr(3y)131.4%
Cap/Depr(5y)89.69%
Cap/Sales(3y)4.14%
Cap/Sales(5y)2.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
EPS Next Y1.46%
EPS Next 2Y10.61%
EPS Next 3Y12.45%
EPS Next 5Y18.96%
Revenue 1Y (TTM)9.64%
Revenue growth 3Y13.2%
Revenue growth 5Y9.05%
Sales Q2Q%11.6%
Revenue Next Year7.1%
Revenue Next 2Y11.23%
Revenue Next 3Y12.25%
Revenue Next 5Y22.12%
EBIT growth 1Y-365.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-11.41%
EBIT Next 3Y7.45%
EBIT Next 5YN/A
FCF growth 1Y-255.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-386.03%
OCF growth 3YN/A
OCF growth 5YN/A